NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is transforming clinical trials with AI powered ...
QuantHealth, an AI-powered drug development platform trusted by the largest pharmaceutical companies, today announced registration has opened for its annual AI in Clinical Development Summit, which ...
The AI in Life Science Market is anticipated to experience a remarkable compound annual growth rate (CAGR) of around 25% in ...
Artificial intelligence (AI) is making significant strides in various fields, with drug discovery being one of the most impactful areas. The process of developing new drugs has traditionally been a ...
XtalPi (2228.HK) today announced the official signing of a strategic R&D collaboration agreement with U.S.-based Kula Bio in ...
O-RAN ALLIANCE continues to uphold its core mission, ensuring that openness fosters interoperability and innovation to drive ...
The global industry 5.0 market in US is expected to be valued at USD 15.0 billion in 2024 and is projected to reach USD 65.1 ...
Mobile health, broadly defined as the use of mobile devices, especially smartphones, for delivering healthcare services, has ...
Chart review has mostly been a manual process, has been prone to error, and is an area where extracting actionable insights ...
Use AI to zero in on the right drug targets, to modernise trials, to find the right participants ... integrated evidence plans, data sharing optimization, infrastruc Get in-depth news, opinions ...
Bees that can detect water in lost hikers' sweat will be tagged with GPS trackers to help locate missing persons ...